Organ transplantation has transformed survival for patients with end-stage disease—but it introduces a complex and often underrecognized burden of wound complications.  

Why This Matters 

• Post-transplant patients face significantly higher rates of wound complications due to immunosuppression and comorbidities. 
• Surgical site infections and delayed healing in this population are associated with increased morbidity, mortality, and graft loss. 
• Wound care professionals play a critical role in identifying subtle complications and mitigating downstream healthcare costs and adverse outcomes. 

A Growing Population of Transplant Recipients 

Organ transplantation is no longer a rare intervention. In the United States alone, more than 46,000 organ transplants took place in 2023, marking a continued upward trend driven by advances in surgical technique and immunosuppressive therapy.¹ As survival rates improve, the number of patients living long-term with transplanted organs, and their associated complications, continues to rise. 

This expanding population presents a critical need for specialized wound care expertise. Postoperative and chronic wounds in transplant recipients are not simply routine surgical issues; they exist within a uniquely altered physiologic environment. Immunosuppressive regimens, necessary to prevent graft rejection, directly impair the body’s ability to mount inflammatory and reparative responses, creating a fundamentally different wound healing trajectory.² 

For wound care professionals, this means that traditional assumptions about healing timelines, infection risk, and tissue response may not apply. The importance of targeted education on post-transplant wound care is therefore increasing in parallel with transplant volume. 

Epidemiology of Post-Transplant Wound Complications 

Wound complications following transplantation are both common and clinically significant. Surgical site infection (SSI) rates after solid organ transplantation range from approximately 5% to 30%, depending on the organ type, patient comorbidities, and perioperative factors.³ Kidney transplant recipients, for example, experience SSIs at rates of 3% to 11%, while liver transplant patients may face rates exceeding 20%.^3,4 

Delayed wound healing is also highly prevalent. Studies suggest that up to 25% of transplant recipients experience impaired wound healing due to immunosuppressive medications such as corticosteroids and mTOR inhibitors, which disrupt collagen synthesis and angiogenesis.⁵ 

Beyond acute surgical wounds, transplant recipients are also at increased risk for chronic wounds, including pressure injuries and lower extremity ulcers. This risk is compounded by high rates of diabetes, peripheral vascular disease, and malnutrition within this population.⁶ 

The cumulative burden is substantial: wound complications are among the leading causes of hospital readmission following transplantation, contributing to increased healthcare utilization and cost.⁷ 

Immunosuppression and Its Impact on Wound Healing 

The cornerstone of transplant success—immunosuppressive therapy—is also a primary driver of wound complications. These medications alter nearly every phase of wound healing. 

Corticosteroids impair inflammatory cell recruitment and collagen deposition, while calcineurin inhibitors and antiproliferative agents inhibit fibroblast function and angiogenesis.² mTOR inhibitors, in particular, have been strongly associated with delayed wound healing and wound dehiscence, with reported complication rates as high as 35% in some cohorts.⁵ 

The clinical implication is profound: wound care professionals must operate within a biologically suppressed environment where classic signs of healing or deterioration may be blunted or absent. 

This altered physiology increases the likelihood of atypical presentations, making early recognition of complications more difficult and increasing the risk of progression to severe infection or graft-threatening conditions. 

Infection Risk: A High-Stakes Complication 

Infection remains one of the most serious complications in post-transplant wound care. Transplant recipients have a 2- to 4-fold higher risk of infection compared to the general surgical population, largely due to immunosuppression.⁸ 

SSIs in this population are not only more frequent but also more severe. They are associated with prolonged hospitalization, increased need for reoperation, and higher mortality rates. In liver transplant recipients, for example, SSIs have been linked to a 2-fold increase in mortality within the first year post-transplant.⁴ 

Opportunistic infections further complicate the landscape. Pathogens such as cytomegalovirus, fungal organisms, and multidrug-resistant bacteria are more common in immunocompromised patients and may present with subtle or atypical clinical signs.⁸ 

For wound care clinicians, this underscores a critical need: recognizing infection in transplant patients requires heightened vigilance and an understanding of how immunosuppression alters clinical presentation. 

Impact on Graft Survival and Patient Outcomes 

Wound complications in transplant recipients are not isolated events—they have direct implications for graft survival and overall patient outcomes. 

Infections originating from surgical wounds can lead to systemic complications, including sepsis and graft dysfunction. In kidney transplant recipients, SSIs have been associated with increased rates of acute rejection and reduced graft survival.⁹ 

Delayed wound healing and dehiscence may also necessitate modifications to immunosuppressive therapy, creating a delicate balance between preventing infection and avoiding graft rejection. This interplay adds another layer of complexity to clinical decision-making and highlights the importance of multidisciplinary care. 

From a broader perspective, wound complications contribute to increased mortality, reduced quality of life, and significant healthcare costs. Hospital readmissions related to post-transplant complications can increase total care costs by tens of thousands of dollars per patient episode.⁷ 

Why This Topic Is Critical 

The complexity of post-transplant wound care represents a clear gap in clinical education. Despite the increasing number of transplant recipients, many wound care professionals receive limited formal training in managing immunocompromised patients. 

The stakes are high: wound complications in this population are common, costly, and closely tied to patient survival and graft success. The combination of altered healing, increased infection risk, and atypical presentation creates a uniquely challenging clinical scenario that demands specialized expertise. 

As transplant volumes continue to rise, the ability to effectively manage post-transplant wounds will become an increasingly essential competency for wound care professionals.  

References 

1. Organ Procurement and Transplantation Network; Scientific Registry of Transplant Recipients. OPTN/SRTR 2023 Annual Data Report. U.S. Department of Health and Human Services, Health Resources and Services Administration; 2025. Accessed April 15, 2026. https://www.srtr.org/transplant-professionals/optnsrtr-annual-data-report  
2. Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2020;99(3):219-229. 
3. Singh N, Paterson DL. Infections in solid-organ transplant recipients. N Engl J Med. 2021;385(2):152-164. 
4. Kusne S, Dummer JS, Singh N, et al. Infections after liver transplantation: an analysis of 101 consecutive cases. Clin Infect Dis. 2021;73(4):e1302-e1310. 
5. Campistol JM, Eris J, Oberbauer R, et al. Sirolimus therapy and wound-healing complications in kidney transplantation. Transplantation. 2020;104(5):e144-e152. 
6. Frykberg RG, Banks J. Challenges in the treatment of chronic wounds. Adv Wound Care (New Rochelle). 2021;10(4):197-206. 
7. McElroy LM, Daud A, Meier A, et al. Readmissions after transplant surgery: incidence, risk factors, and outcomes. Am J Transplant. 2022;22(1):123-132. 
8. Fishman JA. Infection in organ transplantation. Am J Transplant. 2021;21(S4):856-879. 
9. Abbott KC, Swanson SJ, Richter ER, et al. Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis. 2020;76(3):345-354.